Determinants of hospital admission among HIV-positive people in British Columbia

CMAJ. Canadian Medical Association Journal

Volumn 162, Issue 6, 2000, Pages 783-786

  Weber, Amy E ^a   Yip, Benita ^a   O'Shaughnessy, Michael V ^a,c,d   Montaner, Julio S G ^a,c,d   Hogg, Robert S ^a,b,e  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Canadian HIV Trials Network   (Canada)

^e Div of Epidemiol and Pop Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CANADA; FEMALE; HEALTH STATUS; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; UNEMPLOYMENT; VIRUS LOAD;

EID: 0034696609     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. 1. Goedert JJ, Pizza G, Gritti FM, Costigliola P, Boschini A, Bini A, et al. Mortality among drug users in the AIDS era. Int J Epidemiol 1995;24:1204-10.
2. 2. Kozak LJ, McCarthy E, Moien M. Patterns of hospital use by patients with diagnoses related to HIV infection. Public Health Rep 1993;108:571-81.
3. 3. Weissman JS, Cleary PD, Seage GR, Gatsonis C, Haas JS, Chasan-Taber S, et al. The influence of health-related quality of life and social characteristics on hospital use by patients with AIDS in the Boston Health Study. Med Care 1996;34:1037-56.
4. 4. Turner BJ, Kelly JV, Ball KJ. A severity classification system for AIDS hospitalizations. Med Care 1989;27:423-37.
5. 5. Justice AC, Feinstein AR, Wells CK. A new prognostic staging system for the acquired immunodeficiency syndrome. N Engl J Med 1989;320:1388-93.
6. 6. Turner BJ, Markson LE, McKee L, Houchens R, Fanning T. The AIDS-defining diagnosis and subsequent complications: a survival-based severity index. J Acquir Immune Defic Syndr 1991;4:1059-71.
7. 7. Greenfield S, Nelson EC, Zubkoff M, Manning W, Rogers W, Kravitz RL, et al. Variations in resource utilization among medical specialties and systems of care: results from the Medical Outcomes Study. JAMA 1992;267:1624-30.
8. 8. Cleary PD, Greenfield S, Mulley AG, Pauker SG, Schroeder SA, Weder L, et al. Variations in length of stay and outcomes for six medical and surgical conditions in Massachusetts and California. JAMA 1991;266:73-9.
9. 9. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one year recovery in patients undergoing total hip replacement. Med Care 1993;31:141-54.
10. 10. British Columbia Centre for Excellence in HIV/AIDS.Therapeutic guidelines for the treatment of HIV/AIDS and related conditions. Vancouver: The Centre; 1995.
11. 11. Palepu A, Strathdee SA, Hogg RS, Anis AH, Rae S, Cornelisse PGA, et al. The social determinants of emergency department and hospital use by injection drug users in Canada. J Urban Health 1999;76:409-18.
12. 12. Goldstone I, Hogg RS, Schilder A, Pattulo ALS, Sussell R, O'Shaughnessy MV. Unstable housing and its impact on hospital utilisation. Can J Infect Dis 1994;5(Suppl D):33D.
13. 13. Cella DF, Orav EJ, Kornblith AB, Holland JC, Siherfarb PM, Lee KW, et al. Socioeconomic status and cancer survival. J Clin Oncol 1991;9:1500-9.
14. 14. Wilkinson RG. Income distribution and life expectancy. BMJ 1992;304:1120-4.
15. 15. Kitahata MM, Koepsell TD, Deyo RA, Maxwell CL, Dodge WT, Wagner EH. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med 1996;334:701-6.
16. 16. Piatak MJ, Saag MS, Yang LC. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-54.
17. 17. Wain-Hobson S. Virological mayhem. Nature 1995;373:102.
18. 18. Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, et al. HIV viral load markers in clinical practice. Nat Med 1996;2:625-9.
19. 19. Des Jarlais DC, Friedman SR, Choopanya K, Vanichseni S, Ward TP. International epidemiology of HIV and AIDS among injecting drug users. AIDS 1992;6:1053-68.
20. 20. HIV/AIDS surveillance report. Atlanta: US Centers for Disease Control and Prevention; 1993. p. 1-19.
21. 21. Strathdee SA, Patrick DM, Currie SL, Cornelisse PGA, Rekart ML, Montaner JSG, et al. Needle exchange is not enough: lessons from the Vancouver Injecting Drug Use Study. AIDS 1997;11:F59-F65.
22. 22. Seage GR, Oddleifson S, Carr E, Shea B, Makarewicz-Robert L, Van Beuzekom M, et al. Survival with AIDS in Massachusetts, 1979-1989. Am J Public Health 1993;83:72-8.
23. 23. Strathdee SA, Palepu A, Cornelisse PGA, Yip B, O'Shaughnessy MV, Montaner JSG, et al. Barriers to receiving HIV antiretroviral therapy among injection drug users in a universal health care setting. JAMA 1998;280:547-9.
24. 24. Remis RS, Leclerc P, Routledge R, Taylor C, Bruneau J, Beauchemin J, et al. Consortium to characterize injection drug users in Canada (Montreal, Toronto and Vancouver). Ottawa: Division of HIV/AIDS Epidemiology Research, Bureau of HIV/ AIDS and STD, Laboratory Centre for Disease Control, Health Canada; 1998.
25. 25. Gange SJ, Jacobson LP, Kass N, Bing E, Chmiel JS, Zucconi SL, et al. Quality of life among HIV seropositive men on monotherapy and combination antiretroviral therapy [abstract WeB3341]. Int Conf AIDS 1996 July 7-12; 11(2):116.
26. 26. Tisnado DM, Cunningham W, Carlisle D. The impact of hospital AIDS experience on in-hospital AIDS mortality in California. Health Serv Res 1997;14:166-7.
27. 27. Bavry A, Mauldin PD. Resource utilization and stage of illness: a study of an outpatient AIDS clinic. AIDS Patient Care STDS 1996;10:288-91.